FLORHAM PARK, N.J., Sept. 05, 2023 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that members of its management team will participate in the following upcoming investor conferences: Morgan Stanley 21st Annual Global Healthcare Conference…Read More
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
